Current Event

Overview 
Day 1
Day 2
Day 3 
Short Course
PDF Download  
Hotel & Travel 
Distinguished Faculty 
Sponsor & Exhibits 
Press Pass 
Request Brochure 
Archives

 

 

 

microRNA Identification, Profiling and Validation Techniques DVD

March 22, 2010

About the DVD:
The role of microRNA in regulating mammalian development and disease is now well established. miRNAs represent a novel class of targets for therapeutic and diagnostic development, currently not fully exploited by the pharmaceutical and biotechnology industries. This DVD features expert speakers in the pre-conference short course from CHI’s microRNA in Human Disease and Development 2010 meeting addressing technologies used for miRNA identification, profiling and validation involving microarrays, PCR, informatics, etc. Click here for more info

 

CONFERENCE OVERVIEW: 

 TOPICS INCLUDE:

• microRNA in Cancer
• microRNA in Biomarker and Diagnostic Development
• microRNA in Therapeutic Development
• microRNA in Human Development and Disease
• microRNA Pathways and Mechanisms

 

PRE-CONFERENCE SHORT COURSE:

microRNA Identification, Profiling and Validation Techniques

MONDAY, MARCH 22 * 8:00am – 12:00pm

Direct, Electronic microRNA Profiling on a Multiplexed Chip

Shana O. Kelley, Ph.D., Professor, Biochemistry, University of Toronto

The Regulation of microRNA Biogenesis in Cancer and Development

J. Michael Thomson, Ph.D., Assistant Professor, Department of Cancer Biology, Vanderbilt-Ingram Cancer Center

Integrating Micro, Messenger and Non-Coding RNA Expression
Analysis via a Single Array Profiling Platform

Xiaolian Gao, Ph.D., Professor, Biology and Biochemistry, Chemistry, and Biomedical Engineering, Biology and Biochemistry, University of Houston

High-Content Assay to Screen for Modulators of the miRNA Machinery

David Shum, Ph.D., Assay Development Specialist, HTS Core Facility, Memorial Sloan Kettering Cancer Center

Nuclear miRNAs and Cytoplasmic miRNAs

Clark Jeffries, Ph.D., Research Professor, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

microRNAs and Breast Cancer Metastasis: The Power of Pleiotropy

Scott Valastyan, Ph.D., Laboratory of Robert A. Weinberg, Massachusetts Institute of Technology and Whitehead Institute for Biomedical Research

Development and Validation of a miRNA-Based Laboratory Developed Test (LDT) for Pancreatic Cancer

Anna Szafranska-Schwarzbach, Ph.D., CLIA Laboratory Supervisor, Pharmacogenomics Services, Asuragen, Inc.

 

 

Technology Showcase: Sponsored by Discovery of miRNA-Based Biomarkers for Colon Cancer Søren Møller, Ph.D., Vice President, Product Development, Exiqon A/S     Title Sponsored by To be Announced Thomas Schmittgen, Ph.D., Associate Professor, Division of Pharmaceutics, College of Pharmacy, Ohio State University     Sponsored by miRNA Biomarker Profiling from Blood: A Promising Approach for Non-Invasive Diagnostic Testing Peer Staehler, VP Marketing and CSO, febit, Inc.       Sponsored by miRNA Profiling in Context: miRNA and mRNA Profiling of the NCI-60 on the Agilent Microarray Platform Stephanie Fulmer-Smentek, Ph.D., RNA Applications, R&D Group Manager, Biological Systems Division, Agilent Technologies       Sponsored by nCounter™ Analysis System:  A Complete Solution for Detecting and Counting Large Sets of Target miRNA, mRNA, and DNA Molecules in Biological Samples Using Color Coded Tags Stephen Jackson Ph.D., Field Application Scientist, NanoString Technologies, Inc.   Sponsored by Sustained Overexpression of miRNA Mimics using a Lentiviral Delivery System Emily Anderson, Research Scientist, Thermo Scientific Genomics High-Throughput Functional Screening for miRNA Targets Patrick Collins, Ph.D., Director of Research and Development, Switchgear Genomics Sponsored by